<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Extramural venous invasion (EVI) is an important predictor of haematogenous <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, remarkable discrepancies in incidence rates indicate major problems regarding EVI assessment </plain></SENT>
<SENT sid="2" pm="."><plain>The present prospective study applies tangential vessel preparation to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> resection specimens and correlates results of EVI with metachronous haematogenous metastatic (MHM) spread </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Stage II <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> diagnosed at the Institute of Pathology, University Teaching Hospital Feldkirch, Austria over a period of 30 months were analysed and tangential sectioning of the pericolonic tissue was performed </plain></SENT>
<SENT sid="4" pm="."><plain>Confirmation, or exclusion of MHM, as assessed by computerised tomography, sonography or biopsy, was recorded </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In 50/79 (63%) cases EVI was detected </plain></SENT>
<SENT sid="6" pm="."><plain>In 13/50 (26%), MHM developed </plain></SENT>
<SENT sid="7" pm="."><plain>Of the 29/79 (37%) patients without EVI, only one (3.5%) developed MHM </plain></SENT>
<SENT sid="8" pm="."><plain>Statistically, the rate of MHM for patients with EVI was independent of adjuvant chemotherapy </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Tangential sectioning of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> periphery in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> stage II yields a high rate of histologically evaluable extramural veins and permits proper assessment of EVI </plain></SENT>
<SENT sid="10" pm="."><plain>Absence of EVI is significantly associated with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>-free survival, a finding of potential therapeutic value </plain></SENT>
<SENT sid="11" pm="."><plain>On the other hand, one-third of the patients with EVI and circumferential <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> develop MHM, a setting in which the option for adjuvant chemotherapy should be considered </plain></SENT>
<SENT sid="12" pm="."><plain>This study emphasises the importance of tangential sectioning of the invasive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> front in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> compared with the recommended perpendicular technique </plain></SENT>
<SENT sid="13" pm="."><plain>The sensitivity and specificity of this method regarding MHM are characterised </plain></SENT>
</text></document>